Hidenori Mizugaki

Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial

Jun Sato, Miyako Satouchi, Shoichi Itoh et al. · The Lancet Oncology · 2020 · 203 citations

Oncology, Metastatic Thymic Carcinoma, Metronomic Therapy +5

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Hiroaki Akamatsu, Kiichiro Ninomiya, Hirotsugu Kenmotsu et al. · International Journal of Clinical Oncology · 2019 · 145 citations · Full text

CD133 expression: a potential prognostic marker for non-small cell lung cancers

Hidenori Mizugaki, Jun Sakakibara‐Konishi, Junko Kikuchi et al. · International Journal of Clinical Oncology · 2013 · 106 citations

Cancer Research, Potential Prognostic Marker, Oncology +11

Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study

Shintaro Kanda, K. Goto, Hideaki Shiraishi et al. · Annals of Oncology · 2016 · 94 citations · Full text

Epidermal Growth Factor Receptor Mutation Is Associated With Longer Local Control After Definitive Chemoradiotherapy in Patients With Stage III Nonsquamous Non–Small-Cell Lung Cancer

Shigehiro Yagishita, Hidehito Horinouchi, Tomoko Taniyama et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 61 citations

Longer Local Control, Medicine, Pathology +7